Israel Corp (ILCO) - Net Assets
Based on the latest financial reports, Israel Corp (ILCO) has net assets worth ILA6.84 Billion ILA (≈ $18.34 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA13.40 Billion ≈ $35.94 Million USD) and total liabilities (ILA6.57 Billion ≈ $17.60 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Israel Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA6.84 Billion |
| % of Total Assets | 51.02% |
| Annual Growth Rate | 1.89% |
| 5-Year Change | 69.53% |
| 10-Year Change | 134.42% |
| Growth Volatility | 87.64 |
Israel Corp - Net Assets Trend (2000–2024)
This chart illustrates how Israel Corp's net assets have evolved over time, based on quarterly financial data. Also explore ILCO total assets for the complete picture of this company's asset base.
Annual Net Assets for Israel Corp (2000–2024)
The table below shows the annual net assets of Israel Corp from 2000 to 2024. For live valuation and market cap data, see how much is Israel Corp worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA6.38 Billion ≈ $17.11 Million |
+0.25% |
| 2023-12-31 | ILA6.37 Billion ≈ $17.06 Million |
+8.77% |
| 2022-12-31 | ILA5.85 Billion ≈ $15.69 Million |
+36.57% |
| 2021-12-31 | ILA4.29 Billion ≈ $11.49 Million |
+13.84% |
| 2020-12-31 | ILA3.76 Billion ≈ $10.09 Million |
-3.06% |
| 2019-12-31 | ILA3.88 Billion ≈ $10.41 Million |
+7.56% |
| 2018-12-31 | ILA3.61 Billion ≈ $9.68 Million |
+36.90% |
| 2017-12-31 | ILA2.64 Billion ≈ $7.07 Million |
+16.63% |
| 2016-12-31 | ILA2.26 Billion ≈ $6.06 Million |
-16.94% |
| 2015-12-31 | ILA2.72 Billion ≈ $7.30 Million |
-25.12% |
| 2014-12-31 | ILA3.63 Billion ≈ $9.75 Million |
-2.15% |
| 2013-12-31 | ILA3.71 Billion ≈ $9.96 Million |
-10.78% |
| 2012-12-31 | ILA4.16 Billion ≈ $11.16 Million |
-0.05% |
| 2011-12-31 | ILA4.17 Billion ≈ $11.17 Million |
+8.63% |
| 2010-12-31 | ILA3.83 Billion ≈ $10.28 Million |
+15.34% |
| 2009-12-31 | ILA3.33 Billion ≈ $8.91 Million |
-9.05% |
| 2008-12-31 | ILA3.66 Billion ≈ $9.80 Million |
-67.84% |
| 2007-12-31 | ILA11.37 Billion ≈ $30.47 Million |
+418.33% |
| 2006-12-31 | ILA2.19 Billion ≈ $5.88 Million |
+13.59% |
| 2005-12-31 | ILA1.93 Billion ≈ $5.18 Million |
-68.55% |
| 2004-12-31 | ILA6.14 Billion ≈ $16.46 Million |
+50.32% |
| 2003-12-31 | ILA4.08 Billion ≈ $10.95 Million |
+4.45% |
| 2002-12-31 | ILA3.91 Billion ≈ $10.48 Million |
+2.41% |
| 2001-12-31 | ILA3.82 Billion ≈ $10.24 Million |
-6.12% |
| 2000-12-31 | ILA4.07 Billion ≈ $10.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Israel Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 133.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ILA2.60 Billion | 92.44% |
| Common Stock | ILA326.00 Million | 11.58% |
| Other Comprehensive Income | ILA-140.00 Million | -4.97% |
| Other Components | ILA27.00 Million | 0.96% |
| Total Equity | ILA2.82 Billion | 100.00% |
Israel Corp Competitors by Market Cap
The table below lists competitors of Israel Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Central Garden & Pet Company A
NASDAQ:CENTA
|
$1.71 Billion |
|
Camel Group Co Ltd
SHG:601311
|
$1.71 Billion |
|
Shanghai Weaver Network Co Ltd
SHG:603039
|
$1.71 Billion |
|
Peugeot Invest SA
PA:PEUG
|
$1.71 Billion |
|
Jinlongyu Group Co Ltd Class A
SHE:002882
|
$1.71 Billion |
|
Magnite Inc
NASDAQ:MGNI
|
$1.71 Billion |
|
BASF India Limited
NSE:BASF
|
$1.70 Billion |
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
$1.70 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Israel Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,776,000,000 to 2,816,000,000, a change of 40,000,000 (1.4%).
- Net income of 190,000,000 contributed positively to equity growth.
- Dividend payments of 37,000,000 reduced retained earnings.
- Share repurchases of 20,000,000 reduced equity.
- Other comprehensive income decreased equity by 140,000,000.
- Other factors increased equity by 47,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA190.00 Million | +6.75% |
| Dividends Paid | ILA37.00 Million | -1.31% |
| Share Repurchases | ILA20.00 Million | -0.71% |
| Other Comprehensive Income | ILA-140.00 Million | -4.97% |
| Other Changes | ILA47.00 Million | +1.67% |
| Total Change | ILA- | 1.44% |
Book Value vs Market Value Analysis
This analysis compares Israel Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 224.18x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 168.98x to 224.18x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | ILA497.52 | ILA84070.00 | x |
| 2005-12-31 | ILA160.49 | ILA84070.00 | x |
| 2006-12-31 | ILA176.04 | ILA84070.00 | x |
| 2007-12-31 | ILA754.82 | ILA84070.00 | x |
| 2008-12-31 | ILA213.55 | ILA84070.00 | x |
| 2009-12-31 | ILA237.70 | ILA84070.00 | x |
| 2010-12-31 | ILA312.98 | ILA84070.00 | x |
| 2011-12-31 | ILA323.02 | ILA84070.00 | x |
| 2012-12-31 | ILA296.88 | ILA84070.00 | x |
| 2013-12-31 | ILA220.95 | ILA84070.00 | x |
| 2014-12-31 | ILA240.36 | ILA84070.00 | x |
| 2015-12-31 | ILA126.02 | ILA84070.00 | x |
| 2016-12-31 | ILA105.43 | ILA84070.00 | x |
| 2017-12-31 | ILA132.84 | ILA84070.00 | x |
| 2018-12-31 | ILA182.66 | ILA84070.00 | x |
| 2019-12-31 | ILA203.25 | ILA84070.00 | x |
| 2020-12-31 | ILA183.98 | ILA84070.00 | x |
| 2021-12-31 | ILA201.60 | ILA84070.00 | x |
| 2022-12-31 | ILA321.97 | ILA84070.00 | x |
| 2023-12-31 | ILA363.92 | ILA84070.00 | x |
| 2024-12-31 | ILA375.02 | ILA84070.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Israel Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.75%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.78%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 4.44x
- Recent ROE (6.75%) is below the historical average (10.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 6.18% | 1.16% | 0.63x | 8.51x | ILA-79.93 Million |
| 2003 | 14.98% | 3.18% | 0.65x | 7.29x | ILA108.00 Million |
| 2004 | 8.83% | 5.82% | 0.25x | 6.11x | ILA-42.38 Million |
| 2005 | 29.36% | 5.95% | 1.03x | 4.80x | ILA227.22 Million |
| 2006 | 15.16% | 3.07% | 0.98x | 5.06x | ILA69.13 Million |
| 2007 | 1.96% | 1.04% | 0.22x | 8.66x | ILA-462.10 Million |
| 2008 | 19.67% | 1.62% | 1.35x | 9.04x | ILA157.30 Million |
| 2009 | 0.33% | 0.05% | 1.03x | 6.71x | ILA-175.10 Million |
| 2010 | 19.84% | 4.80% | 0.70x | 5.87x | ILA235.10 Million |
| 2011 | 6.13% | 1.30% | 0.76x | 6.23x | ILA-95.50 Million |
| 2012 | -6.45% | -1.27% | 0.73x | 6.93x | ILA-372.40 Million |
| 2013 | -36.80% | -5.62% | 0.70x | 9.29x | ILA-788.50 Million |
| 2014 | 9.44% | 2.83% | 0.43x | 7.79x | ILA-10.30 Million |
| 2015 | 45.79% | 8.14% | 0.50x | 11.22x | ILA343.90 Million |
| 2016 | -14.43% | -2.16% | 0.51x | 12.96x | ILA-196.40 Million |
| 2017 | 13.33% | 2.49% | 0.52x | 10.26x | ILA33.70 Million |
| 2018 | 39.41% | 9.88% | 0.55x | 7.25x | ILA409.70 Million |
| 2019 | 10.19% | 3.00% | 0.50x | 6.86x | ILA3.00 Million |
| 2020 | -12.33% | -3.43% | 0.46x | 7.90x | ILA-313.30 Million |
| 2021 | 5.72% | 1.27% | 0.57x | 7.97x | ILA-65.80 Million |
| 2022 | 38.80% | 9.52% | 0.76x | 5.33x | ILA707.40 Million |
| 2023 | 9.83% | 3.62% | 0.58x | 4.64x | ILA-4.60 Million |
| 2024 | 6.75% | 2.78% | 0.55x | 4.44x | ILA-91.60 Million |
Industry Comparison
This section compares Israel Corp's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $181,628,540
- Average return on equity (ROE) among peers: -3611.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Israel Corp (ILCO) | ILA6.84 Billion | 6.18% | 0.96x | $1.71 Billion |
| Kafrit (KAFR) | $391.79 Million | 16.58% | 0.92x | $172.04 Million |
| Nur Ink Innovations Ltd (NURI) | $35.80K | -21737.67% | 0.15x | $13.92 Million |
| Polyram Plastic Industries Ltd (POLP) | $399.56 Million | 17.73% | 0.98x | $246.74 Million |
| Rimoni (RIMO) | $181.22 Million | 22.77% | 0.25x | $96.75 Million |
| Sonovia Ltd (SONO) | $-154.55K | 0.00% | 0.00x | $1.48K |
| Turpaz Industries Ltd (TRPZ) | $117.33 Million | 10.56% | 0.89x | $2.18 Billion |
About Israel Corp
Israel Corporation Ltd operates in the specialty minerals and chemical businesses in Europe, Asia, South America, North America, and internationally. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The company offers bromine and bromine-based compounds; potash; magnesia, calcium carbonate, and salt products; pure magnesium and magnesium alloy… Read more